Related references
Note: Only part of the references are listed.撤稿声明: Bacteriocins and Their Applications in Food Preservation (Retraction of 10.1080/10408398.2015.1020918, 2015)
R. Ramith et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2020)
Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii
Varsha M. Thomas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
In vitro synergistic activity of erythromycin and nisin against clinical Group B Streptococcus isolates
K. Hayes et al.
JOURNAL OF APPLIED MICROBIOLOGY (2019)
Preclinical studies of toxicity and safety of the AS-48 bacteriocin
Ruben Cebrian et al.
JOURNAL OF ADVANCED RESEARCH (2019)
Cloning, overexpression, purification of bacteriocin enterocin-B and structural analysis, interaction determination of enterocin-A, B against pathogenic bacteria and human cancer cells
Dasari Ankaiah et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Lactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant Enterococcus persistence and promotes Bacteroidetes resilience in the gut following antibiotic challenge
Laureen Crouzet et al.
SCIENTIFIC REPORTS (2018)
Application of Bacteriocins and Protective Cultures in Dairy Food Preservation
Celia C. G. Silva et al.
FRONTIERS IN MICROBIOLOGY (2018)
Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones
Claire Roger et al.
CLINICAL PHARMACOKINETICS (2018)
Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria
Hai Chi et al.
CURRENT MICROBIOLOGY (2018)
Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics
Hasna Hanchi et al.
FUTURE MICROBIOLOGY (2017)
The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity
Delphine L. Caly et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence
Juwon Yim et al.
PHARMACOTHERAPY (2017)
Whole-genome sequencing of mutants with increased resistance against the two-peptide bacteriocin plantaricin JK reveals a putative receptor and potential docking site
Bie Ekblad et al.
PLOS ONE (2017)
Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans
Carrie E. Graham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The Leaderless Bacteriocin Enterocin K1 Is Highly Potent against Enterococcus faecium: A Study on Structure, Target Spectrum and Receptor
Kirill V. Ovchinnikov et al.
FRONTIERS IN MICROBIOLOGY (2017)
A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci
Uraporn Phumisantiphong et al.
PLOS ONE (2017)
Characterization of Vancomycin Resistant Enterococci in Hospitalized Patients and Role of Gut Colonization
Geetarani Purohit et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2017)
VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis
Chatura Prematunge et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2016)
Efficacy of Lantibiotic Treatment of Staphylococcus aureus-Induced Skin Infections, Monitored by In Vivo Bioluminescent Imaging
Anton Du Preez van Staden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Novel Group of Leaderless Multipeptide Bacteriocins from Gram-Positive Bacteria
Kirill V. Ovchinnikov et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2016)
Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections
Evan J. Zasowski et al.
CLINICAL INFECTIOUS DISEASES (2016)
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia
Mehrdad Hefazi et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
A putative amino acid transporter determines sensitivity to the two-peptide bacteriocin plantaricin JK
Camilla Oppegard et al.
MICROBIOLOGYOPEN (2016)
Potentiating the Activity of Nisin against Escherichia coli
Liang Zhou et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
Karrine D. Brade et al.
INFECTIOUS DISEASES AND THERAPY (2016)
Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program
Lalitagauri M. Deshpande et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The Phosphoenolpyruvate:Sugar Phosphotransferase System Is Involved in Sensitivity to the Glucosylated Bacteriocin Sublancin
C. V. Garcia De Gonzalo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci
Ahu Kara et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2015)
Characterization of functional properties of Enterococcus faecium strains isolated from human gut
Humeyra Ispirli et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2015)
Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe
Daniel F. Sahm et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2015)
Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae
Silvia Caballero et al.
PLOS PATHOGENS (2015)
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
Tristan O'Driscoll et al.
INFECTION AND DRUG RESISTANCE (2015)
Prolonged use of oritavancin for vancomycin-resistantEnterococcus faeciumprosthetic valve endocarditis
Jennifer A. Johnson et al.
Open Forum Infectious Diseases (2015)
Vancomycin-Resistant Enterococcal Bacteremia Pharmacotherapy
Ruchi Patel et al.
ANNALS OF PHARMACOTHERAPY (2015)
Structural Variations of the Cell Wall Precursor Lipid II and Their Influence on Binding and Activity of the Lipoglycopeptide Antibiotic Oritavancin
Daniela Muench et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Summary of Linezolid Activity and Resistance Mechanisms Detected during the 2012 LEADER Surveillance Program for the United States
Rodrigo E. Mendes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Circular Bacteriocins: Biosynthesis and Mode of Action
Christina Gabrielsen et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis
Yu-Chung Chuang et al.
BMC INFECTIOUS DISEASES (2014)
Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
Rodrigo E. Mendes et al.
DRUG RESISTANCE UPDATES (2014)
Antimicrobial peptides: new drugs for bad bugs?
Jonathan D. Steckbeck et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Daptomycin activity tested against 164 457 bacterial isolates from hospitalised patients: Summary of 8 years of a Worldwide Surveillance Programme (2005-2012)
Hello S. Sader et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Defining the Structure and Receptor Binding Domain of the Leaderless Bacteriocin LsbB
Kirill V. Ovchinnikov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
An Upp'-turn in bacteriocin receptor identification
Paul D. Cotter
MOLECULAR MICROBIOLOGY (2014)
Vancomycin-resistant enterococci infection: not just for the transplanted
Ashley E. Rosko et al.
LEUKEMIA & LYMPHOMA (2014)
Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications
Rodney H. Perez et al.
MICROBIAL CELL FACTORIES (2014)
Vancomycin-Resistant Enterococcus faecium Bacteremia in a Tertiary Care Hospital: Epidemiology, Antimicrobial Susceptibility, and Outcome
Regis G. Rosa et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Antibacterial activities of bacteriocins: application in foods and pharmaceuticals
Shih-Chun Yang et al.
FRONTIERS IN MICROBIOLOGY (2014)
Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
Sofia Maraki et al.
INFECTION AND CHEMOTHERAPY (2014)
Peptide pheromone signaling in Streptococcus and Enterococcus
Laura C. Cook et al.
FEMS MICROBIOLOGY REVIEWS (2014)
Virulence of Vancomycin-Resistant Enterococcus faecium According to Linezolid Resistance and Clinical Outbreak Status
Milena McLaughlin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections
Anthony M. Casapao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Bacteriocins - a viable alternative to antibiotics?
Paul D. Cotter et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin
Carolina Baldisserotto Comerlato et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2013)
Value Addition in the Efficacy of Conventional Antibiotics by Nisin against Salmonella
Aman Preet Singh et al.
PLOS ONE (2013)
Daptomycin-Resistant Enterococcus faecalis Diverts the Antibiotic Molecule from the Division Septum and Remodels Cell Membrane Phospholipids
Truc T. Tran et al.
MBIO (2013)
Stress Relief during Host Infection: The Phage Shock Protein Response Supports Bacterial Virulence in Various Ways
Andrew J. Darwin
PLOS PATHOGENS (2013)
Microbiota-mediated colonization resistance against intestinal pathogens
Charlie G. Buffie et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Extra cytoplasmic function σ factor activation
Theresa D. Ho et al.
CURRENT OPINION IN MICROBIOLOGY (2012)
Use of Recombinase-Based In Vivo Expression Technology To Characterize Enterococcus faecalis Gene Expression during Infection Identifies In Vivo-Expressed Antisense RNAs and Implicates the Protease Eep in Pathogenesis
Kristi L. Frank et al.
INFECTION AND IMMUNITY (2012)
Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo
A. D. van Staden et al.
JOURNAL OF APPLIED MICROBIOLOGY (2012)
Comparative Analysis of the First Complete Enterococcus faecium Genome
Margaret M. C. Lam et al.
JOURNAL OF BACTERIOLOGY (2012)
Vancomycin-resistant Enterococcus bacteremia: An evaluation of treatment with linezolid or daptomycin
Jennifer D. Twilla et al.
JOURNAL OF HOSPITAL MEDICINE (2012)
The rise of the Enterococcus: beyond vancomycin resistance
Cesar A. Arias et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Antibiotic resistance and virulence traits in clinical and environmental Enterococcus faecalis and Enterococcus faecium isolates
I. U. Rathnayake et al.
SYSTEMATIC AND APPLIED MICROBIOLOGY (2012)
Synergy Between Novel Antimicrobials and Conventional Antibiotics or Bacteriocins
Krystyna I. Wolska et al.
POLISH JOURNAL OF MICROBIOLOGY (2012)
Emergence of Daptomycin-Resistant VRE: Experience of a Single Institution
Mini Kamboj et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
Cesar A. Arias et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Comparison of genotypic and phenotypic cluster analyses of virulence determinants and possible role of CRISPR elements towards their incidence in Enterococcus faecalis and Enterococcus faecium
Angela G. Lindenstrauss et al.
SYSTEMATIC AND APPLIED MICROBIOLOGY (2011)
Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium
K. Hegstad et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Comparison of Outcomes From Daptomycin or Linezolid Treatment for Vancomycin-Resistant Enterococcal Bloodstream Infection: A Retrospective, Multicenter, Cohort Study
Christopher W. Crank et al.
CLINICAL THERAPEUTICS (2010)
Horizontal gene transfer and the genomics of enterococcal antibiotic resistance
Kelli L. Palmer et al.
CURRENT OPINION IN MICROBIOLOGY (2010)
Antimicrobial susceptibility and macrolide resistance genes in Enterococcus faecium with reduced susceptibility to quinupristin-dalfopristin: level of quinupristin-dalfopristin resistance is not dependent on erm(B) attenuator region sequence
Fatima Lopez et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans
Caries Ubeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice
A. M. Brand et al.
LETTERS IN APPLIED MICROBIOLOGY (2010)
Characterization of the ebpfm pilus-encoding operon of Enterococcus faecium and its role in biofilm formation and virulence in a murine model of urinary tract infection
Jouko Sillanpaeae et al.
VIRULENCE (2010)
Evaluation of Nisin F in the Treatment of Subcutaneous Skin Infections, as Monitored by Using a Bioluminescent Strain of Staphylococcus aureus
M. de Kwaadsteniet et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2010)
Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy
Pamela A. Moise et al.
ANNALS OF PHARMACOTHERAPY (2009)
Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization
Oscar Domenech et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Enterococcal surface protein Esp is not essential for cell adhesion and intestinal colonization of Enterococcus faecium in mice
Esther Heikens et al.
BMC MICROBIOLOGY (2009)
Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008)
Helio S. Sader et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Vidya Mave et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Enterococcal Surface Protein Transiently Aggravates Enterococcus faecium-Induced Urinary Tract Infection in Mice
Masja Leendertse et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
Gary J. Patti et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus
M. De Kwaadsteniet et al.
LETTERS IN APPLIED MICROBIOLOGY (2009)
Capacity of human nisin- and pediocin-producing lactic acid bacteria to reduce intestinal colonization by vancomycin-resistant enterococci
Mathieu Millette et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2008)
Prospective evaluation of virulence factors of enterococci isolated from patients with peritonitis: impact on outcome
Herve Dupont et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Katharina Brandl et al.
NATURE (2008)
Cell envelope stress response in Gram-positive bacteria
Sina Jordan et al.
FEMS MICROBIOLOGY REVIEWS (2008)
Enterococcal surface protein esp is important for biofilm formation of Enterococcus faecium E1162
Esther Heikens et al.
JOURNAL OF BACTERIOLOGY (2007)
Five genes encoding surface-exposed LPXTG proteins are enriched in hospital-adapted Enterococcus faecium clonal complex 17 isolates
Antoni P. A. Hendrickx et al.
JOURNAL OF BACTERIOLOGY (2007)
MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection
Katharina Brandl et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Common mechanisms of target cell recognition and immunity for class II bacteriocins
Dzung B. Diep et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E-faecium
Helen L. Leavis et al.
PLOS PATHOGENS (2007)
Molecular epidemiology of hospital-acquired vancomycin-resistant enterococci
Marianne Abele-Horn et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Evidence for a novel protease governing regulated intramembrane proteolysis and resistance to antimicrobial peptides in Bacillus subtilis
Craig D. Ellermeier et al.
GENES & DEVELOPMENT (2006)
Adhesion of vancomycin-resistant Enterococcus to human intestinal mucus
NJ Pultz et al.
CURRENT MICROBIOLOGY (2006)
Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center
Thomas E. Dobbs et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Bacteriocins: Developing innate immunity for food
PD Cotter et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus
DL Higgins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Enterococcal surface protein Esp does not facilitate intestinal colonization or translocation of Enterococcus faecalis in clindamycin-treated mice
NJ Pultz et al.
FEMS MICROBIOLOGY LETTERS (2005)
Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid:: a comparison with quinupristin-dalfopristin
II Raad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens
CJ Donskey
CLINICAL INFECTIOUS DISEASES (2004)
RseP (YaeL), an Escherichia coli RIP protease, cleaves transmembrane sequences
Y Akiyama et al.
EMBO JOURNAL (2004)
Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice
U Stiefel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Outcomes associated with vancomycin-resistant enterococci: A meta-analysis
CD Salgado et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Nonsense mutations in the lsa-like gene in Enterococcus faecalis isolates susceptible to lincosamides and streptogramins A
J Dina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family
SR Nallapareddy et al.
MOLECULAR MICROBIOLOGY (2003)
Characterization of the yaeL gene product and its S2P-protease motifs in Escherichia coli
K Kanehara et al.
GENE (2001)
Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia - A prospective multicenter study
EN Vergis et al.
ANNALS OF INTERNAL MEDICINE (2001)
Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice
S Miyazaki et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2001)
Periplasmic stress and ECF sigma factors
TL Raivio et al.
ANNUAL REVIEW OF MICROBIOLOGY (2001)
Engineering increased stability in the antimicrobial peptide pediocin PA-1
L Johnsen et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)
Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark
FM Aarestrup et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2000)
Drug therapy: Vancomycin-resistant enterococcal infections.
BE Murray
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract
CJ Donskey et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans
MS Brown et al.
CELL (2000)
Share Paper
